These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 3602065)

  • 1. [The polymorphism of drugs in powders and tablets. 1. The preparation and characterization of polymorphic modifications of phenobarbital].
    Traue J; Kala H; Wenzel U; Wiegeleben A; Pintye-Hódi K; Szabó-Révész P; Miseta M; Selmeczi B; Kedvessy G
    Pharmazie; 1987 Feb; 42(2):86-9. PubMed ID: 3602065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The polymorphism of drugs in powders and tablets. 5. Preparation and characterization of polymorphic forms of tolbutamide].
    Traue J; Kala H; Köhler M; Wenzel U; Wiegeleben A; Pintye-Hódi K; Szabó-Révész P; Selmeczi B
    Pharmazie; 1987 Mar; 42(3):181-3. PubMed ID: 3602075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The polymorphism of drugs in powders and tablets. 2. X-ray diffraction studies of polymorphic modifications of phenobarbital].
    Traue J; Kala H; Wenzel U; Förster B; Pintyehódi K; Szabó P; Miseta M; Selmeczi B; Kedvessy G
    Pharmazie; 1986 Apr; 41(4):291-2. PubMed ID: 3725878
    [No Abstract]   [Full Text] [Related]  

  • 4. [On the polymorphism of barbiturates in powders and tablets - Part 3: The effect of the pressing power on the modification of barbital (author's transl)].
    Pintye-Hódi K; Hollenbach K
    Pharmazie; 1979 Dec; 34(12):807-8. PubMed ID: 545349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of powder processing on performance of fenofibrate formulations.
    Jain RA; Brito L; Straub JA; Tessier T; Bernstein H
    Eur J Pharm Biopharm; 2008 Jun; 69(2):727-34. PubMed ID: 18226885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fast-melting tablets based on highly plastic granules.
    Fu Y; Jeong SH; Park K
    J Control Release; 2005 Dec; 109(1-3):203-10. PubMed ID: 16260059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [On the polymorphism of barbiturates in powders and tablets. 6: Properties and behaviour of a spray-dried barbital preparation].
    Matzkó-Hollenbach K; Pintye-Hódi K; Kedvessy G
    Pharmazie; 1982 Aug; 37(8):562-5. PubMed ID: 7146063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advantages of celecoxib nanosuspension formulation and transformation into tablets.
    Dolenc A; Kristl J; Baumgartner S; Planinsek O
    Int J Pharm; 2009 Jul; 376(1-2):204-12. PubMed ID: 19426794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [On the Polymorphism of barbiturates in powders and tablets. Part 4: the dissolution of barbital B and barbital A (modifications I and III and their release from tablets (author's transl)].
    Hollenbach K; Pintye-Hódi K; Kedvessy G
    Pharmazie; 1980 Jan; 35(1):32-5. PubMed ID: 7384174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a laser diffraction method for the determination of the particle size of aerosolised powder formulations.
    Marriott C; MacRitchie HB; Zeng XM; Martin GP
    Int J Pharm; 2006 Dec; 326(1-2):39-49. PubMed ID: 16942848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physical characteristics and aerosol performance of naringin dry powders for pulmonary delivery prepared by spray-drying.
    Sansone F; Aquino RP; Del Gaudio P; Colombo P; Russo P
    Eur J Pharm Biopharm; 2009 May; 72(1):206-13. PubMed ID: 18996478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparation and characterization of nanocrystals for solubility and dissolution rate enhancement of nifedipine.
    Hecq J; Deleers M; Fanara D; Vranckx H; Amighi K
    Int J Pharm; 2005 Aug; 299(1-2):167-77. PubMed ID: 15996838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of powder produced by evaporative precipitation into aqueous solution (EPAS) and spray freezing into liquid (SFL) technologies using novel Z-contrast STEM and complimentary techniques.
    Vaughn JM; Gao X; Yacaman MJ; Johnston KP; Williams RO
    Eur J Pharm Biopharm; 2005 May; 60(1):81-9. PubMed ID: 15848060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of melt granulation and ultrasonic spray congealing as techniques to enhance the dissolution of praziquantel.
    Passerini N; Albertini B; Perissutti B; Rodriguez L
    Int J Pharm; 2006 Aug; 318(1-2):92-102. PubMed ID: 16697539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improving flow properties of ibuprofen by fluidized bed particle thin-coating.
    Ehlers H; Räikkönen H; Antikainen O; Heinämäki J; Yliruusi J
    Int J Pharm; 2009 Feb; 368(1-2):165-70. PubMed ID: 19010403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The polymorphism of drugs in powders and tablets. 4. The effect of the polymorphism of drugs on the physical properties and drug release of phenobarbital tablets].
    Szabó-Réveśz P; Pintye-Hódi K; Miseta M; Selmeczi B; Kedvessy G; Traue J; Kala H; Wenzel U
    Pharmazie; 1987 Mar; 42(3):179-81. PubMed ID: 3602074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Developing a discriminating dissolution test for three mebendazole polymorphs based on solubility differences.
    Swanepoel E; Liebenberg W; Devarakonda B; de Villiers MM
    Pharmazie; 2003 Feb; 58(2):117-21. PubMed ID: 12641328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [On the polymorphism of Barbiturates in powers and tablets. Part 5: The dissolution of recrystallized barbital substances and their release from tablet (author's transl)].
    Hollenbach K; Pintye-Hódi K; Kedvessy G
    Pharmazie; 1980 Feb; 35(2):95-8. PubMed ID: 7384189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Micronization of atorvastatin calcium by antisolvent precipitation process.
    Zhang HX; Wang JX; Zhang ZB; Le Y; Shen ZG; Chen JF
    Int J Pharm; 2009 Jun; 374(1-2):106-13. PubMed ID: 19446766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pore size distribution in tablets measured with a morphological sieve.
    Wu YS; van Vliet LJ; Frijlink HW; van der Voort Maarschalk K
    Int J Pharm; 2007 Sep; 342(1-2):176-83. PubMed ID: 17580106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.